NCT05094804 2023-11-02A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer AgentsOncoResponse, Inc.Phase 1/2 Unknown172 enrolled
NCT01883518 2019-11-20ADCVCTASTN.N. Petrov National Medical Research Center of OncologyPhase 1/2 Unknown48 enrolled